Lore Gruenbaum, Chief Scientific Officer at Blood Cancer United, shared a post on LinkedIn:
“We are delighted to announce that our Blood Cancer United Discovery Grant Program is now open for the 2026-2027 application cycle!
This grant program is designed to fund basic research, technological innovation, and innovative data science to generate actionable insights for blood cancers. We are encouraging applications from senior researchers from academic institutions worldwide.
At Blood Cancer United, we are dedicated to funding the best science to bring better treatments to patients with every form of blood cancer.”
Other articles about Blood Cancer on OncoDaily.